ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
30 hedge funds and large institutions have $26M invested in Zynerba Pharmaceuticals, Inc in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.75M | |
| 2 | +$1.3M | |
| 3 | +$1.12M | |
| 4 |
AAM
Auxier Asset Management
Aurora,
Oregon
|
+$309K |
| 5 |
Two Sigma Investments
New York
|
+$140K |
Top Sellers
| 1 | -$4.53M | |
| 2 | -$660K | |
| 3 | -$151K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$48.3K |
| 5 |
JPMorgan Chase & Co
New York
|
-$48.2K |